The foundation: News

Research

Grifols presents new data to support the effectiveness of its clinical trial to treat Alzheimer's

29/03/2019
Dr. Mercè Boada has participated today in the presentation of the new results of the AMBAR study. These results have been presented by Dr. Antonio Páez (GRIFOLS) at the 14th International Congress on Alzheimer's and Parkinson's (AD / PD) in Lisbon.

Workshop: Scents of memory

25/04/2019Day care and treatment
The Indukern Group organized several aromatherapy workshops this April aimed at foostering the memory of the users of Fundació ACE Daycare Unit.

New genetic study associated with Alzheimer's

24/04/2019Research
Fundació ACE participates in an international study that provides new information about a variant of the BDNF gene, called BDNFVal66Met, associated with Alzheimer's disease and cognitive decline.

Experts encourage reading among people with Alzheimer's

23/04/2019Awareness
On Saint Georges Day, the experts of Fundació ACE recommend reading among people with dementia as a tool to work on language and memory.

Merck discontinues the Verubecestat drug study

16/04/2019Research
Merck discontinued the clinical trial of the Verubecestat drug, performed by Fundació ACE in people with Alzheimer's at a very early stage, after not obtaining the expected results.

The Foundation presents the results of AMBAR at the EADC

12/04/2019Research
Fundació ACE participated this week in the biannual meeting of the European Alzheimer's Disease Consortium (EADC) to present the results of the AMBAR study, a project opening a possible new treatment pathway for Alzheimer's.